|
Other anticoagulants
Citations 11-20 of 93 total displayed.
|
Past content
(since Jan 2001):
|
- Editorials
Adverse Prognostic Significance of Thrombocytopenia in Acute Coronary Syndrome: Can Anything Be Done About It?
- Theodore E. Warkentin and Mark A. Crowther
Circulation 2009;119:2420-2422, doi:10.1161/CIRCULATIONAHA.109.858316
[Full text]
- Editorials
Stopping the Hemorrhage: A New Baseline Bleeding Score Brings Us a Step Closer for Patients With Non–ST-Elevation Myocardial Infarction
- Jeffrey L. Anderson
Circulation 2009;119:1846-1849, doi:10.1161/CIRCULATIONAHA.109.854281
[Full text]
- Clinician Update
Coronary Stents and Chronic Anticoagulation
- Angelos Sourgounis, Janusz Lipiecki, Ted S. Lo, and Martial Hamon
Circulation 2009;119:1682-1688, doi:10.1161/CIRCULATIONAHA.108.834861
[Full text]
- Editorials
Anticoagulation for ST-Segment Elevation Myocardial Infarction
- John W. Eikelboom and Jeffrey I. Weitz
Circulation 2009;119:1186-1188; published online before print as doi:10.1161/CIRCULATIONAHA.108.845552
[Full text]
- Articles
Anticoagulation for ST-Segment Elevation Myocardial Infarction
- John W. Eikelboom and Jeffrey I. Weitz
Circulation published February 23, 2009, doi:10.1161/CIRCULATIONAHA.108.845552
[Abstract]
- Editorials
Early Stent Thrombosis: Past, Present, and Future
- Stéphane Cook and Stephan Windecker
Circulation 2009;119:657-659, doi:10.1161/CIRCULATIONAHA.108.842757
[Full text]
- Coronary Heart Disease
Antithrombotic Therapy With Fondaparinux in Relation to Interventional Management Strategy in Patients With ST- and Non–ST-Segment Elevation Acute Coronary Syndromes: An Individual Patient–Level Combined Analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) Randomized Trials
- Shamir R. Mehta, William E. Boden, John W. Eikelboom, Marcus Flather, P. Gabriel Steg, Alvaro Avezum, Rizwan Afzal, Leopoldo S. Piegas, David P. Faxon, Petr Widimsky, Andrzej Budaj, Susan Chrolavicius, Hans-Jurgen Rupprecht, Sanjit Jolly, Christopher B. Granger, Keith A.A. Fox, Jean-Pierre Bassand, Salim Yusuf for the OASIS 5 and 6 Investigators
Circulation 2008;118:2038-2046; published online before print as doi:10.1161/CIRCULATIONAHA.108.789479
[Abstract]
[Full text]
- Articles
Antithrombotic Therapy With Fondaparinux in Relation to Interventional Management Strategy in Patients With ST- and Non–ST-Segment Elevation Acute Coronary Syndromes. An Individual Patient–Level Combined Analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) Randomized Trials
- Shamir R. Mehta, William E. Boden, John W. Eikelboom, Marcus Flather, P. Gabriel Steg, Alvaro Avezum, Rizwan Afzal, Leopoldo S. Piegas, David P. Faxon, Petr Widimsky, Andrzej Budaj, Susan Chrolavicius, Hans-Jurgen Rupprecht, Sanjit Jolly, Christopher B. Granger, Keith A.A. Fox, Jean-Pierre Bassand, Salim Yusuf for the OASIS 5 and 6 Investigators
Circulation published October 27, 2008, doi:10.1161/CIRCULATIONAHA.108.789479
[Abstract]
- Images in Cardiovascular Medicine
Acute Reversible Bioprosthetic Mitral Valve Stenosis Caused by Heparin-Induced Thrombocytopenia
- Amnon Y. Zlotnick, Jeryes Shehadeh, Moshe Y. Flugelman, Sylvie A. Bursztein-De Myttenaere, Tamar Gaspar, and Avinoam Shiran
Circulation 2008;118:e73-75e, doi:10.1161/CIRCULATIONAHA.107.759498
[Full text]
- Coronary Heart Disease
Phase 1b Randomized Study of Antidote-Controlled Modulation of Factor IXa Activity in Patients With Stable Coronary Artery Disease
- Mark Y. Chan, Mauricio G. Cohen, Christopher K. Dyke, Shelley K. Myles, Laura G. Aberle, Min Lin, James Walder, Steven R. Steinhubl, Ian C. Gilchrist, Neal S. Kleiman, David A. Vorchheimer, Nicholas Chronos, Chiara Melloni, John H. Alexander, Robert A. Harrington, Ross M. Tonkens, Richard C. Becker, and Christopher P. Rusconi
Circulation 2008;117:2865-2874; published online before print as doi:10.1161/CIRCULATIONAHA.107.745687
[Abstract]
[Full text]
|
|
